1.Effectiveness of Pregabalin for Treatment of Burning Mouth Syndrome
Saliha Yeter AMASYALI ; Aslı Akyol GÜRSES ; Osman Nuri AYDIN ; Ali AKYOL
Clinical Psychopharmacology and Neuroscience 2019;17(1):139-142
Treatment of burning mouth syndrome (BMS) is challenging because there is no consensus regarding pharmalogical or nonpharmalogical therapies. The use of anticonvulsants is controversial. We present nine patients BMS who respond to pregabalin. They were diagnosed secondary BMS except two. Etiologic regulations were made firstly in patients with secondary BMS but symptoms did not decrease. We preferred pregabalin in all patients and got good results. Furthermore the addition of pregabalin to the treatment of two patients who did not respond adequately to duloxetine provided good results. We are only aware that pregabalin may reduce symptoms as a result of case reports. We believe that the diagnosis of pathologic etiology with appropriate diagnostic tests will result in better outcomes in treatment.
Anticonvulsants
;
Burning Mouth Syndrome
;
Burns
;
Consensus
;
Diagnosis
;
Diagnostic Tests, Routine
;
Duloxetine Hydrochloride
;
Humans
;
Pregabalin
;
Social Control, Formal
2.Cardiovascular risk may be increased in women with unexplained infertility.
Fatma Ferda VERIT ; Fadile YILDIZ ZEYREK ; Ali Galip ZEBITAY ; Hurkan AKYOL
Clinical and Experimental Reproductive Medicine 2017;44(1):28-32
OBJECTIVE: Growing evidence suggests that increased cardiovascular disease (CVD) risk is associated with female infertility caused by conditions such as polycystic ovarian disease, obesity, thyroid dysfunction, and endometriosis. The aim of this study was to evaluate whether any relationship exists between CVD and unexplained infertility. METHODS: Sixty-five women with unexplained infertility and 65 fertile controls were enrolled in the study. CVD risk markers such as low-density lipoprotein (LDL), high-density lipoprotein (HDL), total cholesterol (TC), triglycerides (TG), insulin resistance (defined by the homeostasis model assessment ratio), and high-sensitivity C-reactive protein (hs-CRP) were assessed. RESULTS: TG, TC, LDL, and hs-CRP levels were higher and HDL levels were lower in patients with unexplained infertility than in fertile controls (p<0.05 for all). Positive associations were found between unexplained infertility and TG, TC, LDL, and hs-CRP levels, and a negative correlation was found for HDL (p<0.05 for all). Multivariate logistic regression analysis showed that TG, HDL, and hs-CRP were independent variables associated with unexplained infertility. CONCLUSION: Our study showed that women with unexplained infertility had an atherogenic lipid profile and elevated hs-CRP levels, suggesting a higher risk of developing CVD in the future. Further studies with larger groups are needed to investigate the nature of this link.
C-Reactive Protein
;
Cardiovascular Diseases
;
Cholesterol
;
Dyslipidemias
;
Endometriosis
;
Female
;
Homeostasis
;
Humans
;
Infertility*
;
Infertility, Female
;
Insulin Resistance
;
Lipoproteins
;
Logistic Models
;
Obesity
;
Ovarian Diseases
;
Risk Factors
;
Thyroid Gland
;
Triglycerides
3.Does bilateral uterine artery ligation have negative effects on ovarian reserve markers and ovarian artery blood flow in women with postpartum hemorrhage?
Fatma Ferda VERIT ; Orkun ÇETIN ; Seda KESKIN ; Hürkan AKYOL ; Ali Galip ZEBITAY
Clinical and Experimental Reproductive Medicine 2019;46(1):30-35
OBJECTIVE: Bilateral uterine artery ligation (UAL) is a fertility-preserving procedure used in women experiencing postpartum hemorrhage (PPH). However, the long-term effects of this procedure on ovarian function remain unclear. The aim of this study was to investigate whether bilateral UAL compromised ovarian reserve and ovarian blood supply. METHODS: This prospective study included 49 women aged between 21 and 36 years who had undergone a cesarean section for obstetric indications. Of these, 25 underwent uterine bilateral UAL to control intractable atonic PPH. The control group consisted of 24 women who had not undergone bilateral UAL. Standard clinical parameters, the results of color Doppler screening, and ovarian reserve markers were assessed in all participants at 6 months after surgery. The clinical parameters included age, parity, cycle history, body mass index, and previous medication and/or surgery. Color Doppler screening findings included the pulsatility index (PI) and resistance index (RI) for both the uterine and ovarian arteries. The ovarian reserve markers included day 3 follicle-stimulating hormone (FSH) levels, antral follicle count, and anti-Müllerian hormone (AMH) levels. RESULTS: There were no significant differences in the ovarian reserve markers of day 3 FSH levels, antral follicle count, and AMH levels between the study and control groups (p>0.05 for all). In addition, no significant differences were observed in the PI and RI indices of the uterine and ovarian arteries (p>0.05 for all). CONCLUSION: In this study, we showed that bilateral UAL had no negative effects on ovarian reserve or ovarian blood supply, so this treatment should be used as a fertility preservation technique to avoid hysterectomy in patients experiencing PPH.
Arteries
;
Body Mass Index
;
Cesarean Section
;
Female
;
Fertility Preservation
;
Follicle Stimulating Hormone
;
Humans
;
Hysterectomy
;
Ligation
;
Mass Screening
;
Ovarian Reserve
;
Parity
;
Postpartum Hemorrhage
;
Postpartum Period
;
Pregnancy
;
Prospective Studies
;
Uterine Artery
4.A Novel Echocardiographic Method for Assessing Arterial Stiffness in Obstructive Sleep Apnea Syndrome.
Serkan AKDAG ; Aytac AKYOL ; Huseyin Altug CAKMAK ; Hulya GUNBATAR ; Muntecep ASKER ; Naci BABAT ; Aydin Rodi TOSU ; Mehmet YAMAN ; Hasan Ali GUMRUKCUOGLU
Korean Circulation Journal 2015;45(6):500-509
BACKGROUND AND OBJECTIVES: Obstructive sleep apnea syndrome (OSAS) is associated with increased arterial stiffness and cardiovascular complications. The objective of this study was to assess whether the color M-mode-derived propagation velocity of the descending thoracic aorta (aortic velocity propagation, AVP) was an echocardiographic marker for arterial stiffness in OSAS. SUBJECTS AND METHODS: The study population included 116 patients with OSAS and 90 age and gender-matched control subjects. The patients with OSAS were categorized according to their apnea hypopnea index (AHI) as follows: mild to moderate degree (AHI 5-30) and severe degree (AHI> or =30). Aortofemoral pulse wave velocity (PWV), carotid intima-media thickness (CIMT), brachial artery flow-mediated dilatation (FMD), and AVP were measured to assess arterial stiffness. RESULTS: AVP and FMD were significantly decreased in patients with OSAS compared to controls (p<0.001). PWV and CIMT were increased in the OSAS group compared to controls (p<0.001). Moreover, AVP and FMD were significantly decreased in the severe OSAS group compared to the mild to moderate OSAS group (p<0.001). PWV and CIMT were significantly increased in the severe group compared to the mild to moderate group (p<0.001). AVP was significantly positively correlated with FMD (r=0.564, p<0.001). However, it was found to be significantly inversely related to PWV (r=-0.580, p<0.001) and CIMT (r=-0.251, p<0.001). CONCLUSION: The measurement of AVP is a novel and practical echocardiographic method, which may be used to identify arterial stiffness in OSAS.
Aorta, Thoracic
;
Apnea
;
Brachial Artery
;
Carotid Intima-Media Thickness
;
Dilatation
;
Echocardiography*
;
Humans
;
Pulse Wave Analysis
;
Sleep Apnea, Obstructive*
;
Vascular Stiffness*